This is a reasonable position, and it is one of the arguments the July panel will need to weigh carefully against the absence of rigorous human trial data
Who Might Benefit from Each Option The Cagrilintide vs Retatrutide decision looks different depending on your health profile
[1] There is no established causal relationship between tirzepatide and swollen lymph nodes (lymphadenopathy) based on current FDA-approved prescribing information and clinical trial data
Furthermore, an index for -cell function, the insulinogenic index (IGI), was measured
If you are new to peptide injections, start with the daily 5/2 schedule
For more focused coverage, see the cluster articles on GHK-Cu for wrinkles and collagen synthesis, topical copper peptide rejuvenation, GHK-Cu and skin barrier repair, and GHK-Cu and photodamage protection